For AI to truly improve and standardize healthcare delivery, we must confront a fundamental issue—the limited and often ...

Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new ...

Postbiotics, derived from beneficial microbes, improve gut health by enhancing barrier function and immune responses, ...

Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy.

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the fourth ...

MindShift's therapists create personalized biofeedback treatment plans tailored to each client's unique needs and goals Californ ...

The Journal chose to focus its five years of the pandemic coverage on asking Triad healthcare providers how we survived, what ...

Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company") today reported financial results for the fourth quarter and fiscal year 2024. Following the completion of the sale of INBRX-101 by Inhibrx, Inc.